Psoriatic Arthritis

Latest News

Amgen to Present New MOSAIC Phase 4 Data at EULAR 2023
Amgen to Present New MOSAIC Phase 4 Data at EULAR 2023

June 1st 2023

Apremilast is being examined for the treatment of psoriatic arthritis.

Janssen Announces Positive Results From Guselkumab Psoriatic Arthritis Trial
Janssen Announces Positive Results From Guselkumab Psoriatic Arthritis Trial

May 31st 2023

Brepocitinib More Efficacious Than Placebo in Long-Term Psoriatic Arthritis Care
Brepocitinib More Efficacious Than Placebo in Long-Term Psoriatic Arthritis Care

May 25th 2023

Cancer Risk in Korean patients With Psoriatic Arthritis Documented
Cancer Risk in Korean patients With Psoriatic Arthritis Documented

April 17th 2023

Izokibep Demonstrates Statistically Significant Improvements in Psoriatic Arthritis
Izokibep Demonstrates Statistically Significant Improvements in Psoriatic Arthritis

April 11th 2023

Latest CME Events & Activities

Burst CME: Improving Outcomes for Your Patient with Vitiligo

View More

Burst CME: Improving Outcomes for Your Patient with Vitiligo

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

View More

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

View More

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options

View More

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

More News

© 2023 MJH Life Sciences

All rights reserved.